-
Signature
-
/s/ Stephen Vander Stoep, attorney-in-fact for Joseph Shulman
-
Stock symbol
-
RYTM
-
Transactions as of
-
Oct 28, 2025
-
Transactions value $
-
-$244,373
-
Form type
-
4
-
Date filed
-
10/30/2025, 04:44 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Shulman Joseph |
Chief Technical Officer |
C/O RHYTHM PHARMACEUTICALS, INC., 222 BERKELEY STREET, 12TH FLOOR, BOSTON |
/s/ Stephen Vander Stoep, attorney-in-fact for Joseph Shulman |
2025-10-30 |
0001909855 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RYTM |
Common Stock |
Options Exercise |
$57.3K |
+2.09K |
+24.61% |
$27.35 |
10.6K |
Oct 28, 2025 |
Direct |
|
| transaction |
RYTM |
Common Stock |
Options Exercise |
$22.1K |
+721 |
+6.8% |
$30.66 |
11.3K |
Oct 28, 2025 |
Direct |
|
| transaction |
RYTM |
Common Stock |
Sale |
-$324K |
-2.82K |
-24.86% |
$115.01 |
8.51K |
Oct 28, 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RYTM |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-2.09K |
-14.29% |
$0.00 |
12.6K |
Oct 28, 2025 |
Common Stock |
2.09K |
$27.35 |
Direct |
F3 |
| transaction |
RYTM |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-721 |
-6.89% |
$0.00 |
9.75K |
Oct 28, 2025 |
Common Stock |
721 |
$30.66 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: